179 related articles for article (PubMed ID: 24525705)
1. A systematic review of the epidemiological literature on the risk of urological cancers in systemic lupus erythematosus.
Huang HB; Jiang SC; Han J; Cheng QS; Dong CB; Pan CM
J Cancer Res Clin Oncol; 2014 Jul; 140(7):1067-73. PubMed ID: 24525705
[TBL] [Abstract][Full Text] [Related]
2. Lung, liver, prostate, bladder malignancies risk in systemic lupus erythematosus: evidence from a meta-analysis.
Ni J; Qiu LJ; Hu LF; Cen H; Zhang M; Wen PF; Wang XS; Pan HF; Ye DQ
Lupus; 2014 Mar; 23(3):284-92. PubMed ID: 24429300
[TBL] [Abstract][Full Text] [Related]
3. An Updated Meta-analysis on the Risk of Urologic Cancer in Patients with Systemic Lupus Erythematosus.
Yeo J; Seo MS; Hwang IC; Shim JY
Arch Iran Med; 2020 Sep; 23(9):614-620. PubMed ID: 32979908
[TBL] [Abstract][Full Text] [Related]
4. No association between the risk of breast cancer and systemic lupus erythematosus: evidence from a meta-analysis.
Rezaieyazdi Z; Tabaei S; Ravanshad Y; Akhtari J; Mehrad-Majd H
Clin Rheumatol; 2018 Jun; 37(6):1511-1519. PubMed ID: 29294194
[TBL] [Abstract][Full Text] [Related]
5. Thyroid cancer in systemic lupus erythematosus: a meta analysis.
Zhang M; Li XM; Wang GS; Qian L; Tao JH; Ma Y; Li XP
Int J Clin Exp Pathol; 2014; 7(9):6270-3. PubMed ID: 25337279
[TBL] [Abstract][Full Text] [Related]
6. Systemic lupus erythematosus and prostate cancer risk: a pool of cohort studies and Mendelian randomization analysis.
Ou J; Zhen K; Wu Y; Xue Z; Fang Y; Zhang Q; Bi H; Tian X; Ma L; Liu C
J Cancer Res Clin Oncol; 2023 Sep; 149(12):9517-9528. PubMed ID: 37213031
[TBL] [Abstract][Full Text] [Related]
7. The risks of cancer development in systemic lupus erythematosus (SLE) patients: a systematic review and meta-analysis.
Song L; Wang Y; Zhang J; Song N; Xu X; Lu Y
Arthritis Res Ther; 2018 Dec; 20(1):270. PubMed ID: 30522515
[TBL] [Abstract][Full Text] [Related]
8. High incidence of potentially virus-induced malignancies in systemic lupus erythematosus: a long-term followup study in a Danish cohort.
Dreyer L; Faurschou M; Mogensen M; Jacobsen S
Arthritis Rheum; 2011 Oct; 63(10):3032-7. PubMed ID: 21953088
[TBL] [Abstract][Full Text] [Related]
9. Gout patients have an increased risk of developing most cancers, especially urological cancers.
Chen CJ; Yen JH; Chang SJ
Scand J Rheumatol; 2014; 43(5):385-90. PubMed ID: 24825466
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune disease and subsequent urological cancer.
Liu X; Ji J; Forsti A; Sundquist K; Sundquist J; Hemminki K
J Urol; 2013 Jun; 189(6):2262-8. PubMed ID: 23228387
[TBL] [Abstract][Full Text] [Related]
11. Systemic lupus erythematous and malignancy risk: a meta-analysis.
Cao L; Tong H; Xu G; Liu P; Meng H; Wang J; Zhao X; Tang Y; Jin J
PLoS One; 2015; 10(4):e0122964. PubMed ID: 25885411
[TBL] [Abstract][Full Text] [Related]
12. The risk of lymphoma development in autoimmune diseases: a meta-analysis.
Zintzaras E; Voulgarelis M; Moutsopoulos HM
Arch Intern Med; 2005 Nov; 165(20):2337-44. PubMed ID: 16287762
[TBL] [Abstract][Full Text] [Related]
13. Cancer risk in a cohort of patients with systemic lupus erythematosus (SLE) in California.
Parikh-Patel A; White RH; Allen M; Cress R
Cancer Causes Control; 2008 Oct; 19(8):887-94. PubMed ID: 18386139
[TBL] [Abstract][Full Text] [Related]
14. Global and regional prevalence and incidence of systemic lupus erythematosus in low-and-middle income countries: a systematic review and meta-analysis.
Fatoye F; Gebrye T; Mbada C
Rheumatol Int; 2022 Dec; 42(12):2097-2107. PubMed ID: 36006459
[TBL] [Abstract][Full Text] [Related]
15. Global Burden of Urologic Cancers, 1990-2013.
Dy GW; Gore JL; Forouzanfar MH; Naghavi M; Fitzmaurice C
Eur Urol; 2017 Mar; 71(3):437-446. PubMed ID: 28029399
[TBL] [Abstract][Full Text] [Related]
16. Smoking and the risk of systemic lupus erythematosus: an updated systematic review and cumulative meta-analysis.
Jiang F; Li S; Jia C
Clin Rheumatol; 2015 Nov; 34(11):1885-92. PubMed ID: 26188616
[TBL] [Abstract][Full Text] [Related]
17. Association of systemic lupus erythematosus autoantibody diversity with breast cancer protection.
Shah AA; Igusa T; Goldman D; Li J; Casciola-Rosen L; Rosen A; Petri M
Arthritis Res Ther; 2021 Feb; 23(1):64. PubMed ID: 33632283
[TBL] [Abstract][Full Text] [Related]
18. Increased cancer risk in patients with cutaneous lupus erythematosus and systemic lupus erythematosus compared with the general population: A Danish nationwide cohort study.
Westermann R; Zobbe K; Cordtz R; Haugaard JH; Dreyer L
Lupus; 2021 Apr; 30(5):752-761. PubMed ID: 33497306
[TBL] [Abstract][Full Text] [Related]
19. Vaccinations and risk of systemic lupus erythematosus and rheumatoid arthritis: A systematic review and meta-analysis.
Wang B; Shao X; Wang D; Xu D; Zhang JA
Autoimmun Rev; 2017 Jul; 16(7):756-765. PubMed ID: 28483543
[TBL] [Abstract][Full Text] [Related]
20. Risk of pancreatic cancer in patients with systemic lupus erythematosus: a meta-analysis.
Seo MS; Yeo J; Hwang IC; Shim JY
Clin Rheumatol; 2019 Nov; 38(11):3109-3116. PubMed ID: 31270697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
